Park WK - Search Results

1

Novel potent blockers for TWIK-1/TREK-1 heterodimers as potential antidepressants.

Lee EH, Park JE, Gotina L, Han YE, Viswanath ANI, Yoo S, Moon B, Hwang JY, Park WK, Cho Y, Song C, Min SJ, Hwang EM, Lee H, Pae AN, Roh EJ, Oh SJ. Lee EH, et al. Among authors: park wk. Biomed Pharmacother. 2023 Sep;165:115139. doi: 10.1016/j.biopha.2023.115139. Epub 2023 Jul 15. Biomed Pharmacother. 2023. PMID: 37454597 Free article.

2

Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110.

Park WK, Jeong D, Yun CW, Lee S, Cho H, Kim GD, Koh HY, Pae AN, Cho YS, Choi KI, Jung JY, Jung SH, Kong JY. Park WK, et al. Pharmacol Res. 2003 Dec;48(6):615-22. doi: 10.1016/s1043-6618(03)00242-1. Pharmacol Res. 2003. PMID: 14527827

3

KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.

Park WK, Jeong D, Cho H, Lee SJ, Cha MY, Pae AN, Choi KI, Koh HY, Kong JY. Park WK, et al. Pharmacol Biochem Behav. 2005 Oct;82(2):361-72. doi: 10.1016/j.pbb.2005.09.006. Epub 2005 Oct 10. Pharmacol Biochem Behav. 2005. PMID: 16216322

4

New serotonin 5-HT(6) ligands from common feature pharmacophore hypotheses.

Kim HJ, Doddareddy MR, Choo H, Cho YS, No KT, Park WK, Pae AN. Kim HJ, et al. Among authors: park wk. J Chem Inf Model. 2008 Jan;48(1):197-206. doi: 10.1021/ci700160t. Epub 2007 Nov 29. J Chem Inf Model. 2008. PMID: 18044950

5

Novel quinazolinone derivatives as 5-HT7 receptor ligands.

Na YH, Hong SH, Lee JH, Park WK, Baek DJ, Koh HY, Cho YS, Choo H, Pae AN. Na YH, et al. Among authors: park wk. Bioorg Med Chem. 2008 Mar 1;16(5):2570-8. doi: 10.1016/j.bmc.2007.11.049. Epub 2007 Nov 22. Bioorg Med Chem. 2008. PMID: 18083580

6

Preparation of piperazine derivatives as 5-HT7 receptor antagonists.

Yoon J, Yoo EA, Kim JY, Pae AN, Rhim H, Park WK, Kong JY, Park Choo HY. Yoon J, et al. Among authors: park choo hy, park wk. Bioorg Med Chem. 2008 May 15;16(10):5405-12. doi: 10.1016/j.bmc.2008.04.023. Epub 2008 Apr 15. Bioorg Med Chem. 2008. PMID: 18456500

7

Identification of novel serotonin 2C receptor ligands by sequential virtual screening.

Ahmed A, Choo H, Cho YS, Park WK, Pae AN. Ahmed A, et al. Among authors: park wk. Bioorg Med Chem. 2009 Jul 1;17(13):4559-68. doi: 10.1016/j.bmc.2009.05.003. Epub 2009 May 8. Bioorg Med Chem. 2009. PMID: 19464901

8

Synthesis and biological evaluation of (phenylpiperazinyl-propyl)arylsulfonamides as selective 5-HT(2A) receptor antagonists.

Yoo E, Yoon J, Pae AN, Rhim H, Park WK, Kong JY, Park Choo HY. Yoo E, et al. Among authors: park choo hy, park wk. Bioorg Med Chem. 2010 Feb 15;18(4):1665-75. doi: 10.1016/j.bmc.2009.12.067. Epub 2010 Jan 4. Bioorg Med Chem. 2010. PMID: 20096593

9

Arylpiperazine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.

Kang SY, Park EJ, Park WK, Kim HJ, Jeong D, Jung ME, Song KS, Lee SH, Seo HJ, Kim MJ, Lee M, Han HK, Son EJ, Pae AN, Kim J, Lee J. Kang SY, et al. Among authors: park ej, park wk. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1705-11. doi: 10.1016/j.bmcl.2010.01.093. Epub 2010 Jan 21. Bioorg Med Chem Lett. 2010. PMID: 20149649

10

Further optimization of novel pyrrole 3-carboxamides for targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.

Kang SY, Park EJ, Park WK, Kim HJ, Choi G, Jung ME, Seo HJ, Kim MJ, Pae AN, Kim J, Lee J. Kang SY, et al. Among authors: park ej, park wk. Bioorg Med Chem. 2010 Aug 15;18(16):6156-69. doi: 10.1016/j.bmc.2010.06.037. Epub 2010 Jun 25. Bioorg Med Chem. 2010. PMID: 20637635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

288 results

Search Page